Drug intelligence / Profile preview

deslorelin

Development stage
Phase 2
Lead developer
Peptech Animal Health
Modality
Peptides
Administration
Subcutaneous, Intramuscular
01

Overview

Deslorelin is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH), classified as a GnRH superagonist or LHRH agonist. It acts by binding to and activating pituitary GnRH receptors, initially causing a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion. With continuous administration, it desensitizes these receptors, leading to suppression of sex hormones such as testosterone and estradiol. This results in reversible inhibition of reproductive function. Deslorelin is primarily used in veterinary medicine for chemical castration, management of adrenocortical disease in ferrets, benign prostatic hyperplasia in dogs, induction of ovulation in horses, suppression of reproductive behaviors in birds and small mammals, and temporary contraception[1][2][3][5][6].

Brand names
SuprelorinSuprelorin-FOvuplantSucromate Equine
Other names
DeslorelinaDeslorelineDeslorelinumSomagard
02

Targets

GnRHR (Gonadotropin-releasing hormone receptor)

Beyond the preview

Go deeper on deslorelin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on deslorelin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call